
The Orange Plague / Story behind the naked, golden ‘king of injustice’
A Jens Galschiøt sculpture at the EU Parliament uses H.C. Andersen’s tale to mock Donald Trump’s world impact.
- Feature
Trending
By Alvi Haque
Feature - -
Graphics: Beyond Headlines / AI assisted
In the Hollywood film Men in Black, a brief flash from a gadget called the Neuralyzer could erase memories in an instant. It was pure science fiction. But the idea that light could influence what happens inside the brain is no longer confined to the screen.
Scientists have found a way to use flashes of light to control the activity of specific nerve cells with extraordinary precision. The technique, known as optogenetics, has transformed how researchers investigate the brain.
Its development earned Karl Deisseroth, Peter Hegemann and Georg Nagel the 2026 Nobel Prize in Physiology or Medicine.
Yet the story began far from the human brain, hidden inside a microscopic green alga carrying a remarkable biological light switch.
For decades, one of neuroscience's biggest challenges was figuring out which neurons controlled specific behaviours, memories and movements.
The human brain contains billions of nerve cells constantly exchanging electrical signals. Scientists could observe these signals, but proving exactly which cells were responsible for a particular action was much harder.
Optogenetics changed that.
By enabling researchers to activate selected neurons using flashes of light -- and, using other light-sensitive proteins, it gave scientists a powerful new way to test cause and effect inside the living brain.
However, light alone could not control a neuron. There had to be a mechanism that translated a beam of light into an electrical signal a cell could understand. The answer lay in a tiny protein discovered in a single-celled green alga. Scientists would eventually turn this biological light switch into a tool that changed how they study the brain.
The story begins with Chlamydomonas, a microscopic alga that swims towards light to find favourable conditions for survival.
Scientists had long wondered how such a simple organism could detect light and convert that information into movement.
Peter Hegemann investigated how the alga responded to light. Working with Georg Nagel and other researchers, he helped uncover the properties of a light-sensitive protein called channelrhodopsin.
What made the protein special was its ability to act as a biological light switch. It could detect light and trigger an electrical change inside the cell.
The discovery revealed a molecular mechanism that converted light into cellular activity, something few researchers could have imagined would one day transform brain science.
Every cell is enclosed by a membrane that controls what moves in and out. Embedded within that membrane are specialised proteins that function like gates, allowing electrically charged particles, known as ions, to pass through.
Channelrhodopsin is one of those proteins, but with a remarkable twist. Its gate opens when exposed to light.
When the appropriate light reaches the protein, a channel opens and charged ions flow across the cell membrane. That movement changes the cell’s electrical state. In nerve cells, such electrical changes can trigger the signals neurons use to communicate.
In simple terms, light does not directly tell a neuron what to do. Instead, it activates a protein, which opens a gate, allowing ions to move and potentially causing the neuron to fire.
Nature had already built the switch. The next question was whether scientists could install that switch somewhere entirely new.
Karl Deisseroth saw the possibility. If neurons could be made to produce channelrhodopsin, perhaps researchers could control their activity using carefully timed flashes of light.
His team introduced the gene responsible for producing the protein into nerve cells.
The result was striking. When blue light was directed at those neurons, the cells responded by firing electrical signals.
In 2005, Deisseroth and his research group published a landmark study demonstrating that light could directly control the activity of mammalian neurons.
An unusual feature evolved by a microscopic alga had become one of neuroscience's most powerful tools. Later work extended the approach to living brains, where researchers could target selected groups of neurons and investigate their roles in behaviour.
The name optogenetics reflects that combination. Genetic techniques are used to equip specific cells with light-sensitive proteins, while light provides precise control over when those cells are activated.
For scientists studying the brain, it opened an entirely new way of asking questions. If a particular group of neurons becomes active during a behaviour, what happens when those neurons are deliberately switched on? What changes when they are silenced?
Questions that once seemed nearly impossible to answer became far more accessible.
Although optogenetics remains primarily a research tool, its influence extends beyond basic neuroscience. Researchers are exploring that possibility in people with severe retinal diseases, including retinitis pigmentosa, a condition in which light-sensitive cells in the retina progressively deteriorate.
But could the same principle help restore a function that has been lost?
One such patient is Robin McCoy, who was diagnosed with the inherited disease that had taken her mother's sight. As her vision deteriorated, everyday activities became increasingly difficult. She eventually stopped driving and began using a cane after an accident.
In 2024, she received an experimental treatment involving optogenetic techniques. A genetically modified virus injected into her right eye with instructions for producing light-sensitive proteins into retinal cells that had survived the disease.
The aim was to make those remaining cells respond to light, potentially allowing them to transmit visual information to the brain even though the retina's original light-sensing cells had been lost.
After her nine-month follow-up, McCoy could sit down on the beach and read a book. She gained two lines of vision on a chart of shrinking letters and gradually reported significant improvements.
Scientists are also using optogenetics to map brain circuits involved in learning, memory, fear, social behaviour and motor control.
The technology is helping researchers investigate the biological mechanisms underlying conditions such as Parkinson's disease, epilepsy, depression, anxiety and Alzheimer's disease.
Its greatest contribution may not be treating disease directly, but revealing how complex neural circuits shape behaviour and health.
The Nobel Prize recognises a discovery that connected two seemingly distant worlds: a microscopic alga drifting through water and the intricate circuitry of the human brain.
Hegemann and Nagel helped uncover nature's light-sensitive switch. Deisseroth showed how that switch could be harnessed to control neurons with unprecedented precision.
Together, they transformed a curious biological feature into a revolutionary scientific tool.
The journey from a single-celled alga to the living brain illustrates how an investigation driven by basic scientific curiosity can lead to discoveries with far-reaching consequences.
Light alone cannot ordinarily tell a neuron what to do. But give that neuron the right biological switch, and light can become a means of controlling its activity.
The crucial discovery was not that light could illuminate the brain. It was that scientists could borrow a molecular mechanism from nature and use it to communicate with the cells inside it.